CD8+ cytotoxic T lymphocytes (CTLs) are the most powerful effectors in the anticancer immune response and are regarded as the main immune cells targeting established and developing tumors (7), through elimination of cancer cells by release of cytotoxic granules and induction of apoptosis (8). The gene discussed is CD8A; the disease is cancer.